1483 related articles for article (PubMed ID: 23886814)
21. Recombinant Human ACE2 and the Angiotensin 1-7 Axis as Potential New Therapies for Heart Failure.
Patel VB; Lezutekong JN; Chen X; Oudit GY
Can J Cardiol; 2017 Jul; 33(7):943-946. PubMed ID: 28279521
[TBL] [Abstract][Full Text] [Related]
22. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.
Lubel JS; Herath CB; Burrell LM; Angus PW
J Gastroenterol Hepatol; 2008 Sep; 23(9):1327-38. PubMed ID: 18557800
[TBL] [Abstract][Full Text] [Related]
23. Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.
Patel VB; Zhong JC; Grant MB; Oudit GY
Circ Res; 2016 Apr; 118(8):1313-26. PubMed ID: 27081112
[TBL] [Abstract][Full Text] [Related]
24. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
Babiker F; Al-Jarallah A; Joseph S
PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
[TBL] [Abstract][Full Text] [Related]
25. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
de Resende MM; Mill JG
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
[TBL] [Abstract][Full Text] [Related]
26. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
[TBL] [Abstract][Full Text] [Related]
27. Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions.
Malfitano C; De Angelis K; Fernandes T; Wichi RB; Rosa K; Pazzine M; Mostarda C; Ronchi FA; Oliveira EM; Casarini DE; Irigoyen MC
J Cardiovasc Pharmacol; 2012 Jan; 59(1):58-65. PubMed ID: 21921804
[TBL] [Abstract][Full Text] [Related]
28. Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.
Molaei A; Molaei E; Hayes AW; Karimi G
Cell Cycle; 2023 Jul; 22(13):1654-1674. PubMed ID: 37365840
[TBL] [Abstract][Full Text] [Related]
29. Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure.
Iwata M; Cowling RT; Yeo SJ; Greenberg B
J Mol Cell Cardiol; 2011 Oct; 51(4):542-7. PubMed ID: 21147120
[TBL] [Abstract][Full Text] [Related]
30. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.
Connelly KA; Advani A; Advani S; Zhang Y; Thai K; Thomas S; Krum H; Kelly DJ; Gilbert RE
Cardiovasc Ther; 2013 Apr; 31(2):84-91. PubMed ID: 21884026
[TBL] [Abstract][Full Text] [Related]
31. The physiological significance of the alternative pathways of angiotensin II production.
Kramkowski K; Mogielnicki A; Buczko W
J Physiol Pharmacol; 2006 Dec; 57(4):529-39. PubMed ID: 17229979
[TBL] [Abstract][Full Text] [Related]
32. Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure.
Barlucchi L; Leri A; Dostal DE; Fiordaliso F; Tada H; Hintze TH; Kajstura J; Nadal-Ginard B; Anversa P
Circ Res; 2001 Feb; 88(3):298-304. PubMed ID: 11179197
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
[TBL] [Abstract][Full Text] [Related]
34. Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart.
Garabelli PJ; Modrall JG; Penninger JM; Ferrario CM; Chappell MC
Exp Physiol; 2008 May; 93(5):613-21. PubMed ID: 18356559
[TBL] [Abstract][Full Text] [Related]
35. Sildenafil Protects against Myocardial Ischemia-Reperfusion Injury Following Cardiac Arrest in a Porcine Model: Possible Role of the Renin-Angiotensin System.
Wang G; Zhang Q; Yuan W; Wu J; Li C
Int J Mol Sci; 2015 Nov; 16(11):27015-31. PubMed ID: 26569234
[TBL] [Abstract][Full Text] [Related]
36. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
[TBL] [Abstract][Full Text] [Related]
37. Renin angiotensin system blockade ameliorates lead nephropathy.
Ng HY; Tain YL; Lee YT; Hsu CY; Chiou TT; Huang PC; Lee CT
Biochem Biophys Res Commun; 2013 Aug; 438(2):359-63. PubMed ID: 23896603
[TBL] [Abstract][Full Text] [Related]
38. Influence of atorvastatin on angiotensin I metabolism in resting and TNF-α -activated rat vascular smooth muscle cells.
Suski M; Gębska A; Olszanecki R; Stachowicz A; Uracz D; Madej J; Korbut R
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):378-83. PubMed ID: 23390189
[TBL] [Abstract][Full Text] [Related]
39. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
40. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
Sandmann S; Unger T
Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
